These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36873397)

  • 1. Predictive value of remnant cholesterol level for all-cause mortality in heart failure patients.
    Zhao L; Zhao X; Tian P; Liang L; Huang B; Huang L; Feng J; Zhang Y; Zhang J
    Front Cardiovasc Med; 2023; 10():1063562. PubMed ID: 36873397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic utility of the prognostic nutritional index combined with serum sodium level in patients with heart failure.
    Zhao L; Zhao X; Tian P; Liang L; Huang B; Huang L; Feng J; Zhang Y; Zhang J
    Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1894-1902. PubMed ID: 35637081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins.
    Wang L; Cong H; Zhang J; Hu Y; Wei A; Zhang Y; Yang H; Ren L; Qi W; Li W
    Front Cardiovasc Med; 2021; 8():718604. PubMed ID: 34368266
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
    Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remnant Cholesterol Predicts Long-term Mortality of Patients With Metabolic Dysfunction-associated Fatty Liver Disease.
    Huang H; Guo Y; Liu Z; Zeng Y; Chen Y; Xu C
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3295-e3303. PubMed ID: 35521833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remnant cholesterol in patients admitted for acute coronary syndromes.
    Cordero A; Alvarez-Alvarez B; Escribano D; García-Acuña JM; Cid-Alvarez B; Rodríguez-Mañero M; Quintanilla MA; Agra-Bermejo R; Zuazola P; González-Juanatey JR
    Eur J Prev Cardiol; 2023 Mar; 30(4):340-348. PubMed ID: 36560864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of short-term follow-up BNP in hospitalized patients with heart failure.
    Khanam SS; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Yoo BS
    BMC Cardiovasc Disord; 2017 Aug; 17(1):215. PubMed ID: 28774268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.
    Edmonston D; Wojdyla D; Mehta R; Cai X; Lora C; Cohen D; Townsend RR; He J; Go AS; Kusek J; Weir MR; Isakova T; Pencina M; Wolf M;
    Am J Kidney Dis; 2019 Dec; 74(6):771-781. PubMed ID: 31445926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).
    Greene SJ; Vaduganathan M; Lupi L; Ambrosy AP; Mentz RJ; Konstam MA; Nodari S; Subacius HP; Fonarow GC; Bonow RO; Gheorghiade M;
    Am J Cardiol; 2013 Feb; 111(4):574-81. PubMed ID: 23206923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left Atrioventricular Coupling Index to Predict Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis.
    Pezel T; Ambale Venkatesh B; Kato Y; De Vasconcellos HD; Heckbert SR; Wu CO; Post WS; Bluemke DA; Cohen-Solal A; Henry P; Lima JAC
    Front Cardiovasc Med; 2021; 8():704611. PubMed ID: 34540915
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure.
    Yuan X; Huang B; Wang R; Tie H; Luo S
    Front Cardiovasc Med; 2022; 9():934551. PubMed ID: 36440019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
    Horace RW; Roberts M; Shireman TI; Merhi B; Jacques P; Bostom AG; Liu S; Eaton CB
    Nephrol Dial Transplant; 2022 Jan; 37(2):382-389. PubMed ID: 33760035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remnant Cholesterol and Cardiovascular Mortality in Patients With Type 2 Diabetes and Incident Diabetic Nephropathy.
    Yu D; Wang Z; Zhang X; Qu B; Cai Y; Ma S; Zhao Z; Simmons D
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3546-3554. PubMed ID: 34291804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein subclasses and cardiovascular disease and mortality in type 2 diabetes: analysis from the Hong Kong Diabetes Biobank.
    Jin Q; Lau ESH; Luk AO; Tam CHT; Ozaki R; Lim CKP; Wu H; Chow EYK; Kong APS; Lee HM; Fan B; Ng ACW; Jiang G; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Cheung EYN; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Yu W; Tsui SKW; Huang Y; Lan HY; Szeto CC; So WY; Jenkins AJ; Chan JCN; Ma RCW;
    Cardiovasc Diabetol; 2022 Dec; 21(1):293. PubMed ID: 36587202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.
    Steffen BT; Guan W; Remaley AT; Paramsothy P; Heckbert SR; McClelland RL; Greenland P; Michos ED; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):448-54. PubMed ID: 25477346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL).
    Holme I; Strandberg TE; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Atherosclerosis; 2009 Aug; 205(2):522-7. PubMed ID: 19327776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.